Show Summary Details

Quick Reference


a drug that prevents cell growth and is administered by mouth mainly to treat chronic myeloid leukaemia. Hydroxycarbamide may lower the white cell content of the blood due to its effects on the bone marrow. Trade name: Hydrea.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.